Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
20/10/2012
20/10/2012
2008
|
Resumo |
Background: The chromosome 17q21.31 microdeletion syndrome is a novel genomic disorder that has originally been identified using high resolution genome analyses in patients with unexplained mental retardation. Aim: We report the molecular and/or clinical characterisation of 22 individuals with the 17q21.31 microdeletion syndrome. Results: We estimate the prevalence of the syndrome to be 1 in 16 000 and show that it is highly underdiagnosed. Extensive clinical examination reveals that developmental delay, hypotonia, facial dysmorphisms including a long face, a tubular or pear-shaped nose and a bulbous nasal tip, and a friendly/amiable behaviour are the most characteristic features. Other clinically important features include epilepsy, heart defects and kidney/urologic anomalies. Using high resolution oligonucleotide arrays we narrow the 17q21.31 critical region to a 424 kb genomic segment (chr17: 41046729-41470954, hg17) encompassing at least six genes, among which is the gene encoding microtubule associated protein tau (MAPT). Mutation screening of MAPT in 122 individuals with a phenotype suggestive of 17q21.31 deletion carriers, but who do not carry the recurrent deletion, failed to identify any disease associated variants. In five deletion carriers we identify a <500 bp rearrangement hotspot at the proximal breakpoint contained within an L2 LINE motif and show that in every case examined the parent originating the deletion carries a common 900 kb 17q21.31 inversion polymorphism, indicating that this inversion is a necessary factor for deletion to occur (p< 10(25)). Conclusion: Our data establish the 17q21.31 microdeletion syndrome as a clinically and molecularly well recognisable genomic disorder. European commission[LSHG-CT-2006-037627] European Commission Netherlands Organisation for Health Research and Development[ZonMW 907-00-058] Netherlands Organisation for Health Research and Development Netherlands Organisation for Health Research and Development[ZonMW 917-86-319] Netherlands Organisation for Health Research and Development Netherlands Organisation for Health Research and Development[ZonMW 920-03-338] Netherlands Organisation for Health Research and Development Netherlands Organisation for Health Research and Development Netherlands Organisation for Health Research and Development[ZonMW 912-04-047] Hersenstichting Nederland Hersenstichting Nederland South Carolina Department of Disabilities and Special Needs (CES) South Carolina Department of Disabilities and Special Needs (CES) National Institutes of Health (NIH)[HD043569] U.S. National Institutes of Health (NIH) |
Identificador |
JOURNAL OF MEDICAL GENETICS, v.45, n.11, p.710-720, 2008 0022-2593 http://producao.usp.br/handle/BDPI/27679 10.1136/jmg.2008.058701 |
Idioma(s) |
eng |
Publicador |
B M J PUBLISHING GROUP |
Relação |
Journal of Medical Genetics |
Direitos |
restrictedAccess Copyright B M J PUBLISHING GROUP |
Palavras-Chave | #PROGRESSIVE SUPRANUCLEAR PALSY #DEPENDENT PROBE AMPLIFICATION #MENTAL-RETARDATION #TAU-GENE #GENOMIC DISORDERS #ARRAY-CGH #OLIGONUCLEOTIDE ARRAYS #STRUCTURAL VARIATION #DEVELOPMENTAL DELAY #DYSMORPHIC FEATURES #Genetics & Heredity |
Tipo |
article original article publishedVersion |